P-206: Antibodies to omicron variants are maintained in newly diagnosed MM patients on lenalidomide, cyclophosphamide, bortezomib and dexamethasone (RCyBorD): results from the UK RADAR/Myeloma XV Trial
- Resource Type
- Source
- Clinical Lymphoma Myeloma and Leukemia. 22:S148-S149
- Subject
Cancer Research Oncology Hematology - Language
- ISSN
- 2152-2650